JAGX Jaguar Health, Inc.
$0.31▼ -1.57%
Healthcare
Other
After hours
$0.32▲ +0.64%
Sep 11, 7:30 PM ET
Volume 388.2K
Avg Volume (10D) 573.9K
Key Metrics & Fundamentals
Market Cap
$1.62M
P/E Ratio
0.0
Div Yield
–%
52W Range
0.30 - 85.40
% vs 50 MA
-72.99%
% vs 200 MA
-97.88%
RSI-14
17.2
MACD Histogram
-0.0200
Beta (1Y vs SPY)
2.97
Free Cash Flow
-$5.34M
Gross Rev
$1.23M
Gross Profit
$194,000
EBITDA
-$1.63M
COGS
$1.03M
Operating Exp
$7.79M
Operating Income
-$7.60M
EBIT
-$7.60M
Pretax Income
-$12.80M
Net Income
-$12.68M
EPS (Diluted)
-15.70
Price & Volume History
Loading chart…
Recent News
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
ACCESS Newswire · Sep 10, 2026 1:00 PM
Jaguar Health Launches Neonorm Dog on Amazon, Expanding Animal-Health Product Franchise
InvestorsHub · Sep 8, 2026 3:06 PM
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
ACCESS Newswire · Sep 8, 2026 1:00 PM
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
ACCESS Newswire · Sep 4, 2026 12:30 PM
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
ACCESS Newswire · Aug 26, 2026 1:00 PM
Jaguar Health Inc (JAGX) (Q2 2026) Earnings Call Highlights: Rare Disease Breakthroughs and ...
GuruFocus.com · Aug 20, 2026 5:02 AM
Jaguar Health Reports Second Quarter 2026 Financials
ACCESS Newswire · Aug 19, 2026 8:00 PM
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
ACCESS Newswire · Aug 18, 2026 1:00 PM
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
ACCESS Newswire · Aug 5, 2026 1:00 PM
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
ACCESS Newswire · Jul 28, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See JAGX's money flow as a full page
Social Sentiment
No Reddit posts found for JAGX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.